{"id":"W2130730771","doi":"10.1634/theoncologist.2007-0245","title":"Optimizing Clinical Benefits of Bisphosphonates in Cancer Patients with Bone Metastases","year":2010,"lang":"en","type":"article","venue":"The Oncologist","topic":"Bone health and treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"Novartis Pharmaceuticals Corporation; Amgen","keywords":"Medicine; Denosumab; Zoledronic acid; Breast cancer; Clinical trial; Osteonecrosis of the jaw; Internal medicine; Multiple myeloma; Oncology; Adverse effect; Cancer; Surgery; Osteoporosis; Bisphosphonate","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003372677,0.00009567956,0.0003502366,0.00003518957,0.0000439492,0.000003270453,0.00006508524,0.00007693077,0.00008797782],"category_scores_gemma":[0.0001241489,0.00004801876,0.00004262365,0.0001517036,0.0002455236,0.00002892369,0.00003109212,0.0002941832,0.000007706563],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003937495,"about_ca_system_score_gemma":0.0001952053,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003497724,"about_ca_topic_score_gemma":0.008222076,"domain_scores_codex":[0.9991278,0.00004149309,0.0003321438,0.0001509301,0.0001499008,0.0001977316],"domain_scores_gemma":[0.9991979,0.0002425674,0.0001654449,0.0002133506,0.0000874218,0.00009330278],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001026632,0.001309459,0.9576613,0.00002263944,0.00005061566,0.00001150956,0.00007829804,0.00002210833,0.00001734011,0.00008759941,0.0001994727,0.03951301],"study_design_scores_gemma":[0.004835989,0.001319577,0.9914365,0.00006895864,0.0001247186,0.000003713009,0.00002971326,0.00002399807,0.000620781,0.0000193398,0.001460863,0.00005585069],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968101,0.0007097814,9.731389e-7,0.001178635,0.0002140874,0.0004386951,0.00003807664,0.00001544878,0.0005941458],"genre_scores_gemma":[0.9969604,0.0002111443,0.002086171,0.0004763094,0.00002298056,0.00005120571,0.00001970364,0.00001079636,0.0001613144],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03945716,"threshold_uncertainty_score":0.5287535,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0494458585787789,"score_gpt":0.3779195865178927,"score_spread":0.3284737279391138,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}